Ekopak NV (EBR:EKOP)

Verve Therapeutics Revenue

In the year 2024, Ekopak NV had annual revenue of 47.64M EUR with 32.21% growth. Ekopak NV had revenue of 15.06M in the half year ending December 31, 2024, with 47.08% growth.

• Revenue: 47.64M
• Revenue Growth: +32.21%
• P/S Ratio: 2.76
• Revenue / Employee: 173.86K
• Employees: 285
• Market Cap: 131.27M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	47.64M	11.61M	32.21%
Dec 31, 2023	36.03M	18.32M	103.46%
Dec 31, 2022	17.71M	6.46M	57.41%
Dec 31, 2021	11.25M	1.77M	18.69%
Dec 31, 2020	9.48M	-726.00K	-7.11%